nicotine has been researched along with Brain Disorders in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Brahmi, N; Elaloui, E; Rjeibi, I; Saad, AB; Zouari, N | 1 |
| Arzua, T; Bai, X; Jiang, C; Yan, Y | 1 |
| Alkadhi, KA | 1 |
| Chang, CC; Chang, HA; Chen, TY; Chu, CS; Tzeng, NS | 1 |
| Hall, BJ; Levin, ED; Rezvani, AH | 1 |
| Abdolahi, A; Benesch, CG; Block, RC; Scott, BE; Spitzer, EM; van Wijngaarden, E; Wang, HZ; Williams, GC | 1 |
| Akaike, A; Izumi, Y; Kume, T; Takada-Takatori, Y | 1 |
| Hunter, RG | 1 |
| Goriounova, NA; Mansvelder, HD | 1 |
| Amerio, G; Frøen, JF; Saugstad, OD; Stray-Pedersen, B | 1 |
| Denk, LD; Rogers, AJ; Wax, PM | 1 |
| Charriez, CM; Guseva, MV; Pauly, JR; Scheff, SW | 1 |
| Eriksson, P; Fredriksson, A; Johansson, N | 1 |
| Arneric, SP; Bannon, AW; Brioni, JD; Decker, MW | 1 |
| Riekkinen, M; Riekkinen, P; Sirviö, J | 2 |
| Chambers, RA; Levin, ED; McEvoy, JP; Moore, J | 1 |
| Changeux, JP; Léna, C | 1 |
| Brioni, JD; Morgan, SJ; O'Neill, AB | 1 |
| Arun, P; Deepadevi, KV; Kurup, PA; Manojkumar, V; Ravikumar, A | 1 |
| Changeux, JP; Evrard, P; Gressens, P; Laudenbach, V; Medja, F; Rossi, FM; Zoli, M | 1 |
| Raine, A | 1 |
10 review(s) available for nicotine and Brain Disorders
| Article | Year |
|---|---|
The importance of non-coding RNAs in environmental stress-related developmental brain disorders: A systematic review of evidence associated with exposure to alcohol, anesthetic drugs, nicotine, and viral infections.
Topics: Anesthetics; Brain Diseases; Humans; MicroRNAs; Nicotine; RNA, Untranslated; Virus Diseases | 2021 |
Neuroprotective Effects of Nicotine on Hippocampal Long-Term Potentiation in Brain Disorders.
Topics: Animals; Brain Diseases; Hippocampus; Humans; Long-Term Potentiation; Neuroprotective Agents; Nicotine | 2018 |
Heterogeneity across brain regions and neurotransmitter interactions with nicotinic effects on memory function.
Topics: Animals; Brain; Brain Diseases; Memory; Nicotine; Receptors, Nicotinic | 2015 |
Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain; Brain Diseases; Cholinesterase Inhibitors; Cytoprotection; Humans; Neuroprotective Agents; Nicotine; Rats; Receptors, Nicotinic; Synaptic Transmission | 2010 |
Stress and the α7 nicotinic acetylcholine receptor.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain Diseases; Drug Delivery Systems; Humans; Hypothalamo-Hypophyseal System; Nicotine; Pituitary-Adrenal System; Receptors, Nicotinic; Stress, Psychological | 2012 |
Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function.
Topics: Adolescent; Animals; Brain Diseases; Cognition Disorders; Executive Function; Ganglionic Stimulants; Humans; Nerve Net; Neurons; Nicotine; Prefrontal Cortex; Rats; Smoking; Synapses; Up-Regulation | 2012 |
Nicotinic receptor modulation for neuroprotection and enhancement of functional recovery following brain injury or disease.
Topics: Animals; Brain Diseases; Disease Models, Animal; Drug Administration Schedule; Humans; Mice; Neuroprotective Agents; Nicotine; Receptors, Nicotinic; Recovery of Function | 2004 |
Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics.
Topics: Analgesia; Animals; Anxiety; Brain; Brain Diseases; Cerebrovascular Circulation; Cognition; Discrimination Learning; Humans; Nicotine; Receptors, Nicotinic | 1995 |
Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders.
Topics: Amino Acid Sequence; Animals; Brain Diseases; Cholinergic Agents; Humans; Molecular Sequence Data; Nicotine; Receptors, Nicotinic | 1997 |
Annotation: the role of prefrontal deficits, low autonomic arousal, and early health factors in the development of antisocial and aggressive behavior in children.
Topics: Adolescent; Adult; Aggression; Autonomic Nervous System Diseases; Birth Injuries; Brain Diseases; Child; Child Behavior Disorders; Child Nutrition Disorders; Female; Heart Rate; Humans; Male; Nicotine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects | 2002 |
12 other study(ies) available for nicotine and Brain Disorders
| Article | Year |
|---|---|
Nicotine-induced oxidative stress, testis injury, AChE inhibition and brain damage alleviated by Mentha spicata.
Topics: Acetylcholinesterase; Animals; Antioxidants; Brain; Brain Diseases; Catalase; Cholinesterase Inhibitors; Glutathione; Glutathione Peroxidase; Lipid Peroxidation; Male; Mentha spicata; Nicotine; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Sperm Motility; Spermatozoa; Superoxide Dismutase; Testis | 2020 |
Killing two birds with one stone: the potential role of aripiprazole for patients with comorbid major depressive disorder and nicotine dependence via altering brain activity in the anterior cingulate cortex.
Topics: Antidepressive Agents, Second-Generation; Aripiprazole; Brain; Brain Diseases; Bupropion; Comorbidity; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Gyrus Cinguli; Humans; Nicotine; Serotonin; Smoking; Tobacco Use Disorder; Treatment Outcome | 2014 |
Damage to the insula leads to decreased nicotine withdrawal during abstinence.
Topics: Brain Diseases; Brain Ischemia; Cerebral Cortex; Female; Hospitalization; Humans; Longitudinal Studies; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Stroke; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2015 |
Detrimental effects of nicotine and endotoxin in the newborn piglet brain during severe hypoxemia.
Topics: Animals; Animals, Newborn; Blood Pressure; Brain Diseases; Corpus Striatum; Endotoxins; Escherichia coli; Glutamic Acid; Glycerol; Hydrogen-Ion Concentration; Hypoxia; Lactic Acid; Microdialysis; Nicotine; Oxygen; Pyruvic Acid; Swine; Tumor Necrosis Factor-alpha | 2002 |
Catastrophic brain injury after nicotine insecticide ingestion.
Topics: Adolescent; Brain Diseases; Drug Overdose; Emergency Medical Services; Humans; Hypoxia, Brain; Insecticides; Male; Nicotine; Treatment Outcome | 2004 |
Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice.
Topics: Alkanesulfonic Acids; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Brain Diseases; Caprylates; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Fluorocarbons; Locomotion; Male; Maze Learning; Mental Disorders; Mice; Nicotine; Nicotinic Agonists; Pregnancy; Time Factors | 2008 |
Effects of nicotine on neocortical electrical activity in rats.
Topics: Animals; Brain Diseases; Cerebral Cortex; Cholinergic Fibers; Electroencephalography; Electrophysiology; Male; Mecamylamine; Nicotine; Parasympatholytics; Rats; Rats, Wistar; Substantia Innominata; Tacrine | 1993 |
Cholinergic drugs regulate passive avoidance performance via the amygdala.
Topics: Amygdala; Animals; Arecoline; Avoidance Learning; Behavior, Animal; Brain Diseases; Male; Mecamylamine; Muscarinic Antagonists; Nicotine; Nicotinic Antagonists; Parasympathomimetics; Rats; Rats, Wistar; Receptors, Muscarinic; Receptors, Nicotinic; Scopolamine; Substantia Innominata | 1993 |
Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia.
Topics: Amphetamine; Animals; Behavior, Animal; Brain Diseases; Central Nervous System Stimulants; Disease Models, Animal; Female; Hippocampus; Ibotenic Acid; Male; Maze Learning; Mecamylamine; Memory; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Random Allocation; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Scopolamine | 1996 |
Histological and behavioral protection by (-)-nicotine against quinolinic acid-induced neurodegeneration in the hippocampus.
Topics: Animals; Brain Diseases; Cognition Disorders; Hippocampus; Male; Maze Learning; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Nicotine; Quinolinic Acid; Rats; Spatial Behavior | 1998 |
Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders.
Topics: Adult; Biogenic Monoamines; Brain Diseases; Brain Neoplasms; Digoxin; Epilepsy, Generalized; Erythrocytes; Fatty Acids, Nonesterified; Female; Glioma; Glycine Agents; Humans; Hydroxymethylglutaryl CoA Reductases; Kynurenic Acid; Magnesium; Male; Microvascular Angina; Middle Aged; Morphine; Narcotics; Nicotine; Nicotinic Agonists; Parkinson Disease; Quinolinic Acid; Schizophrenia; Serum Albumin; Sodium-Potassium-Exchanging ATPase; Strychnine; Tryptophan; Tyrosine; Ubiquinone | 2000 |
Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Animals, Newborn; Autoradiography; Brain Diseases; Cell Death; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Agonists; Ibotenic Acid; Injections; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Neurological; N-Methylaspartate; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic | 2002 |